Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (1), 69-76
- https://doi.org/10.1016/s0190-9622(98)70541-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cyclosporine as maintenance therapy in patients with severe psoriasisJournal of the American Academy of Dermatology, 1997
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATIONTransplantation, 1996
- Section Reviews: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthnlis: New therapeutic approaches to atopic dermatitisExpert Opinion on Investigational Drugs, 1996
- MANAGING ADULTS WITH ATOPIC DERMATITISDermatologic Clinics, 1996
- The Practical Management of Atopic Dermatitis in ChildrenPediatric Annals, 1996
- Therapeutic Drug Monitoring of Tacrolimus in Clinical TransplantationTherapeutic Drug Monitoring, 1995
- Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointmentBritish Journal of Dermatology, 1995
- Pharmacokinetics of tacrolimus in liver transplant patients*Clinical Pharmacology & Therapeutics, 1995
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986